Dermatology Clinical Trials in Ontario

Clinical Research

Advancing Care for Inflammatory Skin Conditions

York Dermatology Clinic & RC takes part in dermatology clinical trials in Ontario from our clinic in Richmond Hill. Our ongoing studies, currently in Phase 2 to Phase 4, focus on immune-mediated inflammatory skin conditions.

For more information about our clinical trials, or to see if you may qualify, please email research@yorkderm.ca or send us an enquiry using the form below.

Phase 2 to Phase 4 clinical trials

Six immune-mediated skin condition areas

Questions? Email research@yorkderm.ca

How to Take Part

Review the Conditions

See the skin conditions we currently study and the trials registered at our clinic.

Email Our Research Team

Email research@yorkderm.ca to ask whether you may qualify for a study.

Send an Enquiry

Complete the clinical trials enquiry form and our research team will follow up.

Conditions We Study

Our current studies focus on the immune-mediated inflammatory skin conditions below. Studies marked Recruiting are enrolling new participants; others are underway and no longer enrolling. Study information is from ClinicalTrials.gov and may change, so please email research@yorkderm.ca to confirm whether you may qualify.

Alopecia Areata & Hair Loss

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, causing patchy hair loss on the scalp or body.

Studies at our clinic:

Upadacitinib tablets in adults and adolescents with severe alopecia areata
Phase 3 · Recruiting · NCT06012240 on ClinicalTrials.gov
Real-world study of the burden of alopecia areata, vitiligo or hidradenitis suppurativa in adolescents and adults
Observational · Recruiting · NCT07136467 on ClinicalTrials.gov
PP405 in adult men with androgenetic alopecia (pattern hair loss)
Phase 2/3 · Recruiting · NCT07819435 on ClinicalTrials.gov

Atopic Dermatitis

Atopic dermatitis (eczema) is a chronic inflammatory skin condition that causes dry, itchy and inflamed skin, often in flares.

Studies at our clinic:

Upadacitinib in adults with moderate-to-severe atopic dermatitis and an inadequate response to dupilumab
Phase 3 · Active, not recruiting · NCT06389136 on ClinicalTrials.gov
BFB759 in moderate to severe atopic dermatitis
Phase 2 · Active, not recruiting · NCT07105488 on ClinicalTrials.gov
JNJ-95597528 in moderate to severe atopic dermatitis
Phase 2 · Active, not recruiting · NCT07230860 on ClinicalTrials.gov

Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory condition that causes painful nodules, abscesses and tunnels under the skin, most often in the underarms, groin and other skin folds.

Studies at our clinic:

Povorcitinib in adolescents with moderate to severe hidradenitis suppurativa
Phase 2 · Recruiting · NCT07213973 on ClinicalTrials.gov
Real-world study of the burden of alopecia areata, vitiligo or hidradenitis suppurativa in adolescents and adults
Observational · Recruiting · NCT07136467 on ClinicalTrials.gov
Upadacitinib in adults and adolescents with moderate to severe HS who have not responded to anti-TNF therapy
Phase 3 · Active, not recruiting · NCT05889182 on ClinicalTrials.gov
Lutikizumab in adults and adolescents with moderate to severe hidradenitis suppurativa
Phase 3 · Active, not recruiting · NCT06468228 on ClinicalTrials.gov
BFB759 in moderate to severe hidradenitis suppurativa
Phase 2/3 · Active, not recruiting · NCT07287644 on ClinicalTrials.gov
Tulisokibart (MK-7240) in hidradenitis suppurativa
Phase 2 · Active, not recruiting · NCT06956235 on ClinicalTrials.gov
Tibulizumab in hidradenitis suppurativa
Phase 2 · Active, not recruiting · NCT06993610 on ClinicalTrials.gov

Psoriasis & Psoriatic Arthritis

Psoriasis is an immune-mediated condition that causes thick, scaly plaques on the skin. Some people with psoriasis also develop psoriatic arthritis, which causes joint pain and swelling.

Studies at our clinic:

JNJ-77242113 in moderate to severe plaque psoriasis
Phase 3 · Active, not recruiting · NCT06143878 on ClinicalTrials.gov
JNJ-77242113 for plaque psoriasis involving the scalp, genitals, palms or soles
Phase 3 · Active, not recruiting · NCT06095102 on ClinicalTrials.gov

Urticaria & Prurigo Nodularis

Chronic urticaria causes recurring hives and itching that last six weeks or longer. Prurigo nodularis causes firm, intensely itchy nodules on the skin.

Studies at our clinic:

Barzolvolimab in chronic spontaneous urticaria
Phase 3 · Active, not recruiting · NCT06455202 on ClinicalTrials.gov

Vitiligo

Vitiligo is an autoimmune condition that causes patches of skin to lose their pigment.

Studies at our clinic:

Ritlecitinib capsules over 104 weeks in adults with nonsegmental vitiligo
Phase 3 · Active, not recruiting · NCT06072183 on ClinicalTrials.gov
Real-world study of the burden of alopecia areata, vitiligo or hidradenitis suppurativa in adolescents and adults
Observational · Recruiting · NCT07136467 on ClinicalTrials.gov

Clinical Trials Enquiry

Tell us which condition or study you are interested in and our research team will follow up. You can also email research@yorkderm.ca.

Location

Visit Our Richmond Hill Clinic

York Dermatology Clinic & RC
245 West Beaver Creek Rd., Unit 2
Richmond Hill, Ontario L4B 1L1

Phone: (905) 883-7997
Fax: (905) 883-7994

Monday – Friday: 8:30 AM – 4:30 PM
Saturday & Sunday: Closed